HCW Biologics Inc. (HCWB) vs VivoSim Labs, Inc. (VIVS)

A side-by-side comparison of HCW Biologics Inc. and VivoSim Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HCWB

HCW Biologics Inc.

$545796

$1.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VIVS

VivoSim Labs, Inc.

$518606

$0.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HCWB vs VIVS

growth of $100 · dividends reinvested · last 1y

HCWB -96.4% (-96.4%/yr)VIVS -88.0% (-88.0%/yr)VIVS compounded faster over this window

HCWB VIVS

HCWB vs VIVS: by the numbers

•HCWB is the larger company ($545796 vs $518606 market cap).
•Both run net losses; HCWB's is the smaller (-73.22% vs -11016.07% net margin).

Metrics side by side

Valuation

Metric	HCWB	VIVS
P/S ratio	0.08	4.63
P/B ratio	0.07	N/A

Profitability

Metric	HCWB	VIVS
Gross margin	20.00%	100.00%
Operating margin	-20757.65%	-8567.94%
Net margin	-73.22%	-11016.07%
ROE	-66.26%	N/A
ROIC	-41.92%	-579.89%

Growth (annualized)

Metric	HCWB	VIVS
Revenue CAGR (5Y)	-57.90%	N/A
Total return CAGR (5Y)	-69.71%	N/A

Go deeper

Full HCWB analysis Full VIVS analysis Interactive comparison tool

Dig into the metrics

HCW Biologics ROE VivoSim Labs ROE HCW Biologics operating margin VivoSim Labs operating margin HCW Biologics revenue growth VivoSim Labs revenue growth HCW Biologics free cash flow VivoSim Labs free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.